Łacina P - Search Results

1

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma.

Łacina P, Butrym A, Frontkiewicz D, Mazur G, Bogunia-Kubik K. Łacina P, et al. Curr Issues Mol Biol. 2022 Jan 14;44(1):350-359. doi: 10.3390/cimb44010026. Curr Issues Mol Biol. 2022. PMID: 35723405 Free PMC article.

2

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

Butrym A, Rybka J, Łacina P, Gębura K, Frontkiewicz D, Bogunia-Kubik K, Mazur G. Butrym A, et al. Among authors: lacina p. Leuk Res. 2015 Dec;39(12):1462-6. doi: 10.1016/j.leukres.2015.10.007. Epub 2015 Oct 19. Leuk Res. 2015. PMID: 26521987

3

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

Butrym A, Łacina P, Rybka J, Chaszczewska-Markowska M, Mazur G, Bogunia-Kubik K. Butrym A, et al. Among authors: lacina p. Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):151-156. doi: 10.1007/s00005-016-0442-6. Epub 2017 Jan 12. Arch Immunol Ther Exp (Warsz). 2016. PMID: 28083618 Free PMC article.

4

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.

Wróbel T, Butrym A, Łacina P, Rybka J, Gębura K, Mazur G, Bogunia-Kubik K. Wróbel T, et al. Among authors: lacina p. Anticancer Res. 2017 Apr;37(4):1799-1803. doi: 10.21873/anticanres.11514. Anticancer Res. 2017. PMID: 28373444

5

From genetic single candidate gene studies to complex genomics of GvHD.

Bogunia-Kubik K, Łacina P. Bogunia-Kubik K, et al. Among authors: lacina p. Br J Haematol. 2017 Sep;178(5):661-675. doi: 10.1111/bjh.14704. Epub 2017 Apr 26. Br J Haematol. 2017. PMID: 28444735 Free article. Review.

6

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.

Butrym A, Łacina P, Kuliczkowski K, Bogunia-Kubik K, Mazur G. Butrym A, et al. Among authors: lacina p. BMC Cancer. 2018 Jan 30;18(1):107. doi: 10.1186/s12885-018-4045-y. BMC Cancer. 2018. PMID: 29382303 Free PMC article.

7

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients.

Łacina P, Butrym A, Mazur G, Bogunia-Kubik K. Łacina P, et al. Genes (Basel). 2018 Apr 24;9(5):226. doi: 10.3390/genes9050226. Genes (Basel). 2018. PMID: 29695106 Free PMC article.

8

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma.

Łacina P, Butrym A, Humiński M, Dratwa M, Frontkiewicz D, Mazur G, Bogunia-Kubik K. Łacina P, et al. Mol Carcinog. 2021 Feb;60(2):106-112. doi: 10.1002/mc.23272. Epub 2020 Dec 7. Mol Carcinog. 2021. PMID: 33283899

9

TERT-Regulation and Roles in Cancer Formation.

Dratwa M, Wysoczańska B, Łacina P, Kubik T, Bogunia-Kubik K. Dratwa M, et al. Among authors: lacina p. Front Immunol. 2020 Nov 19;11:589929. doi: 10.3389/fimmu.2020.589929. eCollection 2020. Front Immunol. 2020. PMID: 33329574 Free PMC article. Review.

10

Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells.

Bogunia-Kubik K, Łacina P. Bogunia-Kubik K, et al. Among authors: lacina p. Int J Immunogenet. 2021 Apr;48(2):157-171. doi: 10.1111/iji.12523. Epub 2020 Dec 22. Int J Immunogenet. 2021. PMID: 33352617 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page